{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:29:27Z","timestamp":1791595767390,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.msard.2025.106962","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:17:03Z","timestamp":1767208623000},"page":"106962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Therapeutic plasma exchange for MOG antibody-associated disease attacks: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3675-0957","authenticated-orcid":false,"given":"Roger Santana","family":"de Araujo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Trajano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Carnero Contentti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Schwake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Ayzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Kazutoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Boaventura","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarso","family":"Adoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagoberto","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Luisa","family":"Ap\u00f3stolos-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2025.106962_bib0067","article-title":"Uncovering the diagnostic challenge of myelin oligodendrocyte glycoprotein antibody-associated disease: a case study of acute bilateral vision loss","volume":"16","author":"Anto","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0021","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0073","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106962_bib0029","series-title":"27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)","article-title":"Acute disseminated encephalomyelitis requiring decompressive craniectomy as initial presentation of MOG-antibody disorders in adults","author":"Chavarria-Miranda","year":"2011"},{"key":"10.1016\/j.msard.2025.106962_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104237","article-title":"Details and outcomes of a large cohort of MOG-IgG associated optic neuritis","volume":"68","author":"Chen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106962_bib0012","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2025.106962_bib0076","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2023.02.013","article-title":"Visual outcomes following plasma exchange for optic neuritis: an international multicenter retrospective analysis of 395 optic neuritis attacks","volume":"252","author":"Chen","year":"2023","journal-title":"Am. J. Ophthalmol."},{"issue":"15 Suppl","key":"10.1016\/j.msard.2025.106962_bib0059","doi-asserted-by":"crossref","first-page":"P1.090","DOI":"10.1212\/WNL.90.15_supplement.P1.090","article-title":"Treatment-refractory anti-MOG antibody encephalomyelitis in an adult man (P1.090)","volume":"90","author":"Cipriani","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0015","article-title":"Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: data from a nationwide registry in Argentina","volume":"7","author":"Contentti","year":"2021","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2025.106962_bib0071","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1137998","article-title":"Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease","volume":"14","author":"Corbali","year":"2023","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2025.106962_bib0043","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/13524585211057512","article-title":"MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination","volume":"28","author":"Dams","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106962_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578295","article-title":"Therapeutic plasma exchange for neuromyelitis optica attacks: evidence and challenges from a real-world cohort from Brazil","volume":"388","author":"de Almeida","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106962_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-022-02420-2","article-title":"Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study","volume":"19","author":"Demuth","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.msard.2025.106962_bib0010","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/ene.14746","article-title":"The long-term outcome of MOGAD: an observational national cohort study of 61 patients","volume":"28","author":"Deschamps","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.msard.2025.106962_bib0041","first-page":"P788","article-title":"MOG-ab positive acute disseminated encephalomyelitis with asymmetric lesions in basal ganglia and in thalami","volume":"49","author":"Egger","year":"2018","journal-title":"Neuropediatrics"},{"issue":"6","key":"10.1016\/j.msard.2025.106962_bib0045","first-page":"P388","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody related disease","volume":"114","author":"Ennis","year":"2021","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.msard.2025.106962_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211070684","article-title":"MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report","volume":"15","author":"Escol\u00e0","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"15","key":"10.1016\/j.msard.2025.106962_bib0055","doi-asserted-by":"crossref","first-page":"e1577","DOI":"10.1212\/WNL.0000000000207637","article-title":"Pearls & oy-sters: MOG-AD meningoencephalitis with holocord gray matter predominant myelitis","volume":"101","author":"Farkas","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0054","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/01658107.2023.2172434","article-title":"Paracentral acute middle maculopathy associated with severe anti-mog (myelin oligodendrocyte glycoprotein)-positive optic neuritis","volume":"47","author":"Fernandes","year":"2023","journal-title":"Neuroophthalmology"},{"issue":"Suppl 1","key":"10.1016\/j.msard.2025.106962_bib0057","first-page":"223","article-title":"Plasmapheresis as a fundamental treatment in acute transverse myelitis","volume":"117","author":"Fonseca","year":"2022","journal-title":"Vox Sang"},{"issue":"9","key":"10.1016\/j.msard.2025.106962_bib0061","article-title":"Aggressive course of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): an illustration of two cases and review of literature","volume":"16","author":"Frade","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.msard.2025.106962_bib0019","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40120-022-00344-w","article-title":"Efficacy of plasma exchange treatment for demyelinating optic neuritis associated with various serum antibodies: a prospective cohort study","volume":"11","author":"Fu","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2025.106962_bib0065","article-title":"Myelin oligodendrocyte glycoprotein G antibody-positive paraneoplastic myelopathy in Seminoma: a case report and literature review","author":"Hamid","year":"2024","journal-title":"Neurohospitalist"},{"issue":"Suppl 1","key":"10.1016\/j.msard.2025.106962_bib0031","first-page":"91","article-title":"An unusual case presentation of MOG-positive acute disseminated encephalomyelitis (ADEM) in a preschool child","volume":"64","author":"Hasan","year":"2022","journal-title":"Dev. Med. Child Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0039","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/a-1068-2506","article-title":"First clinical experience with anti-myelin oligodendrocyte glycoprotein antibody-positive optic neuritis","volume":"237","author":"Heckmann","year":"2020","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.msard.2025.106962_bib0069","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2023"},{"issue":"1","key":"10.1016\/j.msard.2025.106962_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.msard.2025.106962_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577521","article-title":"COVID-19, HHV6 and MOG antibody: a perfect storm","volume":"353","author":"Jumah","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.msard.2025.106962_bib0009","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.msard.2025.106962_bib0064","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) initially presenting as septic meningoencephalitis in a 16-year-old male","volume":"11","author":"Karavassilis","year":"2024","journal-title":"Eur. J. Case Rep. Intern. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106962_bib0072","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ana.26226","article-title":"Complement activation is a prominent feature of MOGAD","volume":"90","author":"Keller","year":"2021","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2025.106962_bib0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106962_bib0022","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.msard.2025.106962_bib0049","first-page":"357","article-title":"Myelin oligodendrocyte glycoprotein-IgG-positive disease associated with herpes simplex virus infection to central nervous system: distinct clinical and radiological features in 2 cases","volume":"25","author":"Kopp","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106962_bib0011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jns.2018.11.029","article-title":"The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis","volume":"396","author":"Liu","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0028","first-page":"193","article-title":"A case of refractory MOG-IgG-related disorder treated with rituximab","volume":"12","author":"Matsumoto","year":"2021","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.msard.2025.106962_bib0036","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200150","article-title":"Dramatic response to Anti-IL-6 receptor therapy in children with life-threatening myelin oligodendrocyte glycoprotein-associated disease","volume":"10","author":"McLendon","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0025","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1212\/NXI.0000000000000088","article-title":"A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies","volume":"2","author":"Morris","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.msard.2025.106962_bib0070","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200275","article-title":"MOG CNS autoimmunity and MOGAD","volume":"11","author":"Moseley","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2025.106962_bib0058","first-page":"71","article-title":"Refractory case of myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis with lumbosacral radiculitis","volume":"11","author":"Nakamura","year":"2020","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106962_bib0046","doi-asserted-by":"crossref","unstructured":"Nahrir, Shahpar, Naim Izet Kajtazi and Jameelah A. Saeedi. Myelin Oligodendrocyte Glycoprotein (MOG) Associated Neuromyelitis Optica (NMO) Presenting with Isolated Absent F Wave. (2016). doi:10.19104\/JNN.2016.23.","DOI":"10.19104\/jnn.2016.23"},{"key":"10.1016\/j.msard.2025.106962_bib0023","unstructured":"National Heart, Lung, and Blood Institute (NHLBI). Study Quality Assessment Tools. NIH, 2014. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"10.1016\/j.msard.2025.106962_bib0027","unstructured":"Oberoi, Vaibhav & Zaid, Ghaida & Agnihotri, Shruti. (2023). A case of MOGAD with multiple large cystic brain lesions. 10.1177\/13524585231169437."},{"issue":"8","key":"10.1016\/j.msard.2025.106962_bib0026","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5692\/clinicalneurol.cn-001868","article-title":"[A case of anti-myelin oligodendrocyte glycoprotein antibody-positive multiphasic disseminated encephalomyelitis showing significant recovery after immunoadsorption plasmapheresis]","volume":"63","author":"Ogawa","year":"2023","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5692\/clinicalneurol.cn-001685","article-title":"[An 11 year old woman with myelin-oligodendrocyte glycoprotein antibody showing various phenotypes of central nervous system disorders in one year]","volume":"62","author":"Oshibe","year":"2022","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J. Clin. Apher."},{"issue":"7","key":"10.1016\/j.msard.2025.106962_bib0044","first-page":"NP16","article-title":"Myelin oligodendrocyte glycoprotein associated disorder presenting with longitudinally extensive transverse myelitis after BNT162b2-COVID-19 booster vaccination: a case report","volume":"29","author":"Park","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2025.106962_bib0035","series-title":"American Neurological Association 2021 Annual Meeting","article-title":"COVID-19 presenting as anti-MOG syndrome with longitudinally extensive transverse myelitis: a case report","author":"Rana","year":"2021"},{"key":"10.1016\/j.msard.2025.106962_bib0038","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.936361","article-title":"Encephalitis with extensive cortical brain magnetic resonance imaging changes secondary to myelin oligodendrocyte glycoprotein antibody disease","volume":"23","author":"Satyasi","year":"2022","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.msard.2025.106962_bib0020","article-title":"Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks","author":"Schwake","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106962_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1258043","article-title":"A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0005","first-page":"312","article-title":"Reassessing seronegative NMOSD: the role of MOG antibodies","volume":"50","author":"Silva","year":"2022","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106962_bib0047","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12886-023-03280-x","article-title":"Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report","volume":"24","author":"Sorensen","year":"2024","journal-title":"BMC Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0074","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1212\/NXI.0000000000000572","article-title":"Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?","volume":"6","author":"Stiebel-Kalish","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"Suppl 27","key":"10.1016\/j.msard.2025.106962_bib0051","first-page":"S219","article-title":"Neuroinflammation in the post-partum period: an unusual presentation of myelin oligodendrocyte antibody disease","volume":"92","author":"Suarez","year":"2022","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106962_bib0048","article-title":"Myelin oligodendrocyte glycoprotein optic neuritis presenting with orbital apex syndrome","volume":"15","author":"Sulaiman","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0063","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200249","article-title":"MOG antibody-associated disease in the setting of metastatic melanoma complicated by immune checkpoint inhibitor use","volume":"11","author":"Syc-Mazurek","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.msard.2025.106962_bib0037","first-page":"421","article-title":"Effective plasmapheresis treatment of intractable visual symptoms of MOG antibody-related disorders","volume":"54","author":"Takeuchi","year":"2022","journal-title":"No To Hattatsu"},{"issue":"7_Supplement_1","key":"10.1016\/j.msard.2025.106962_bib0068","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210879","article-title":"Effectiveness and outcome predictors of acute plasma exchange for myelin oligodendrocyte glycoprotein antibody associated disease (S38.004)","volume":"104","author":"Thakolwiboon","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106962_bib0024","unstructured":"Thakolwiboon, Smathorn & Redenbaugh, Vyanka & Cacciaguerra, Laura & Tisavipat, Nanthaya & Tajfirouz, Deena & Chiriboga, Alfonso & Tillema, Jan-Mendelt & Lotan, Itay & Forcadela, Mirasol & clemence, boutiere & Audoin, Bertrand & Pique, Julie & Vasileiou, Eleni & Sotirchos, Elias & Henderson, Amanda & Champsas, Dimitrios & Maillart, Elisabeth & Villarreal Navarro, Sylvia & Moss, Heather & Chen, John. (2023). Efficacy and outcome predictors of acute plasma exchange for myelin oligodendrocyte glycoprotein antibody associated disease. 10.1177\/13524585231196191."},{"issue":"6","key":"10.1016\/j.msard.2025.106962_bib0018","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213903","article-title":"Outcomes after acute plasma exchange for myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"105","author":"Thakolwiboon","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106962_bib0077","unstructured":"TIMELY-PLEX: Treatment of inflammatory myelitis and optic neuritis with early vs rescue plasma exchange. ClinicalTrials.gov Identifier: NCT07100990."},{"issue":"10","key":"10.1016\/j.msard.2025.106962_bib0032","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2169\/internalmedicine.0394-22","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody-positive myelitis after Coronavirus Disease 2019","volume":"62","author":"Uchino","year":"2023","journal-title":"Intern. Med."},{"key":"10.1016\/j.msard.2025.106962_bib0042","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2018.02.006","article-title":"MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis","volume":"21","author":"Vecchio","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0062","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200243","article-title":"Life-threatening MOG antibody-associated hemorrhagic ADEM with elevated CSF IL-6","volume":"11","author":"Virupakshaiah","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0006","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/WNO.0000000000001583","article-title":"Recovery of vision in myelin oligodendrocyte glycoprotein-IgG optic neuritis without treatment: a case series","volume":"43","author":"Vosoughi","year":"2023","journal-title":"J. Neuroophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/01616412.2022.2129760","article-title":"Myelin oligodendrocyte glycoprotein antibodies in NMOSD seronegative patients: a reclassification perspective","volume":"45","author":"Wang","year":"2023","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.msard.2025.106962_bib0001","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann. Neurol."},{"issue":"Suppl 7","key":"10.1016\/j.msard.2025.106962_bib0052","first-page":"S249","article-title":"Neuromyelitis optica with optic chiasm involvement associated with MOG antibody","volume":"184","author":"Welaratne","year":"2015","journal-title":"Ir. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.msard.2025.106962_bib0017","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00415-020-10026-y","article-title":"Treatment of MOG antibody associated disorders: results of an international survey","volume":"267","author":"Whittam","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106962_bib0066","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/01658107.2023.2290540","article-title":"Peripheral retinal haemorrhages in a patient with MOG-associated optic neuritis","volume":"48","author":"Wilke","year":"2024","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.msard.2025.106962_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.598531","article-title":"Case report: myelin oligodendrocyte glycoprotein antibody-associated relapse with COVID-19","volume":"11","author":"Woodhall","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2025.106962_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2023.03.002","article-title":"Two cases of juvenile myelomonocytic leukemia and myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"144","author":"Yamamoto","year":"2023","journal-title":"Pediatr. Neurol."},{"issue":"350","key":"10.1016\/j.msard.2025.106962_bib0002","article-title":"Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: a systematic review and meta-analysis","volume":"20","author":"Yu","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2025.106962_bib0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00415-017-8651-4","article-title":"Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai","volume":"265","author":"Zhao","year":"2018","journal-title":"China. J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106962_bib0056","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/19418744231192159","article-title":"Perplexing initial presentations of MOGAD in two children: intracranial hypertension and new-onset seizure","volume":"13","author":"Zhou","year":"2023","journal-title":"Neurohospitalist"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482500700X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482500700X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:48:33Z","timestamp":1780415313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482500700X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":76,"alternative-id":["S221103482500700X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106962","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange for MOG antibody-associated disease attacks: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106962"}}